Search

everythinglearnresearchcommunity

for

Search:↓

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

People with early hair loss may have higher insulin levels and a greater chance of developing metabolic syndrome.

Mild essential fatty acid deficiency can cause health issues and is worsened by low-fat diets.

The document concludes that more research is needed to fully understand the causes of PCOS.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Men with hair loss have higher BMI, waist size, blood pressure, and are linked to smoking and inactivity.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Men with early balding may have hormonal imbalances similar to women with PCOS and could benefit from similar treatments.

Premature graying of hair is linked to various health issues and can sometimes be reversed by treating underlying conditions.

Gray hair is caused by reduced melanin production or transfer issues, linked to aging and possibly health conditions, with treatments focusing on color camouflage.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Finasteride, a hair loss medication, may be linked to stroke in young men.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Most people in Turkey start getting gray hair around 33 years old, with factors like age, education, hair loss, skin type, family history, and anxiety playing a role.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Adults with trichotillomania do not have different pain sensitivity to cold pressor pain compared to healthy individuals.

Androgen use may increase the risk of stroke, but more research is needed.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Skin tags in obese individuals may indicate higher cardiovascular risk.

Prediabetes may be a risk factor for hair loss.